| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PNAS..11215172Y |
| P356 | DOI | 10.1073/PNAS.1422015112 |
| P932 | PMC publication ID | 4679044 |
| P698 | PubMed publication ID | 26598706 |
| P50 | author | Adrian Harris | Q37374768 |
| P2093 | author name string | Francesca M Buffa | |
| Chunxu Qu | |||
| Jun Yang | |||
| Jiannis Ragoussis | |||
| Dilair Baban | |||
| Andrew M Davidoff | |||
| Rodrigo B Interiano | |||
| Ji-Liang Li | |||
| Esther Bridges | |||
| Robert Nicholson | |||
| Dylan T Jones | |||
| Alaa AlTahan | |||
| Nathan Vogt | |||
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related | Q24806403 | ||
| Activating ESR1 mutations in hormone-resistant metastatic breast cancer | Q27852630 | ||
| ESR1 ligand-binding domain mutations in hormone-resistant breast cancer | Q27852637 | ||
| Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis | Q28200184 | ||
| Connections and regulation of the human estrogen receptor | Q28201958 | ||
| Open source clustering software | Q29547702 | ||
| A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations | Q29614275 | ||
| Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263 | Q31814776 | ||
| Cellular and molecular pharmacology of antiestrogen action and resistance | Q31921111 | ||
| An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients | Q33519584 | ||
| A CTCF-independent role for cohesin in tissue-specific transcription | Q33812535 | ||
| Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer | Q33845160 | ||
| XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway | Q33926690 | ||
| Overexpression of POLQ confers a poor prognosis in early breast cancer patients | Q34051213 | ||
| Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients | Q34141028 | ||
| FOXA1 is a key determinant of estrogen receptor function and endocrine response | Q34508204 | ||
| The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth | Q34664804 | ||
| The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription | Q35143427 | ||
| High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. | Q36029877 | ||
| Estrogen receptor target gene: an evolving concept | Q36362136 | ||
| Small-molecule activation of p53 blocks hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia | Q37145375 | ||
| NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha | Q37158836 | ||
| Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta | Q37268581 | ||
| Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer | Q37472659 | ||
| Biological determinants of endocrine resistance in breast cancer | Q37585095 | ||
| Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases | Q37618868 | ||
| Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer | Q40020433 | ||
| Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. | Q40101179 | ||
| Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists | Q40714917 | ||
| Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer | Q40952791 | ||
| Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade | Q42510471 | ||
| Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene | Q42739835 | ||
| The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. | Q43154570 | ||
| Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia | Q43270175 | ||
| Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. | Q43913511 | ||
| Hypoxia-Inducible Factor-1 Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer | Q58211875 | ||
| Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer | Q59289357 | ||
| Hypoxia-inducible factor 1: master regulator of O2 homeostasis | Q77485489 | ||
| Hypoxia and estrogen co-operate to regulate gene expression in T-47D human breast cancer cells | Q80256412 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15172-15177 | |
| P577 | publication date | 2015-11-23 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer | |
| P478 | volume | 112 |
| Q55119106 | BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer. |
| Q58210984 | Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo |
| Q57109688 | Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT |
| Q47836759 | Deciphering metabolic rewiring in breast cancer subtypes |
| Q64255931 | Deciphering the Molecular Mechanisms Sustaining the Estrogenic Activity of the Two Major Dietary Compounds Zearalenone and Apigenin in ER-Positive Breast Cancer Cell Lines |
| Q91277769 | Disinfection Byproducts Bind Human Estrogen Receptor-α |
| Q64974925 | Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy. |
| Q46727445 | Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue |
| Q37327681 | Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells |
| Q92281756 | Gene Expression Assays for Early-Stage Hormone Receptor-Positive Breast Cancer: Understanding the Differences |
| Q64236018 | HIF-1α-Deficiency in Myeloid Cells Leads to a Disturbed Accumulation of Myeloid Derived Suppressor Cells (MDSC) During Pregnancy and to an Increased Abortion Rate in Mice |
| Q36998209 | HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells. |
| Q48225818 | Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer. |
| Q64968674 | Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. |
| Q37662078 | Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells |
| Q59812894 | Icariin promotes the migration of bone marrow stromal cells via the SDF-1α/HIF-1α/CXCR4 pathway |
| Q89237242 | Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data |
| Q64245167 | Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications |
| Q38755956 | MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha |
| Q64922459 | Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression. |
| Q26749333 | Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction |
| Q99594542 | Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS |
| Q59810728 | Single-cell RNA-sequencing reveals transcriptional dynamics of estrogen-induced dysplasia in the ovarian surface epithelium |
| Q92643741 | The Functions of DNA Damage Factor RNF8 in the Pathogenesis and Progression of Cancer |
| Q92479149 | The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer |
| Q98185640 | Tumorigenesis and Progression As A Consequence of Hypoxic TME：A Prospective View upon Breast Cancer Therapeutic Targets |
| Q96131917 | USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer |
| Q90697973 | miR-939-3p promotes epithelial-mesenchymal transition and may be used as a prognostic marker in hepatocellular carcinoma |
Search more.